# Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-long-term-treatment-with-teneligliptin-interim-analysis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takashi Kadowaki,Masakazu Haneda,Hiroshi Ito,Makoto Ueno,Miyuki Matsukawa,Tomoko Yamakura,Kazuyo Sasaki,Mayumi Kimura,Hiroaki Iijima |
| Citations | 13 |
| DOI | 10.1080/14656566.2017.1420165 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1420165?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2780972107 |
| PMID | 29268035 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Miyuki Matsukawa](https://scholariq.org/researchers/miyuki-matsukawa/)

## Paper journal

- [Expert Opinion on Pharmacotherapy](https://scholariq.org/journals/expert-opinion-on-pharmacotherapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.